Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis

被引:111
作者
Lanciego, Jose L. [1 ,2 ,3 ]
Barroso-Chinea, Pedro [1 ,2 ,3 ]
Rico, Alberto J. [1 ,2 ,3 ]
Conte-Perales, Lorena [1 ,2 ,3 ]
Callen, Lucia [3 ]
Roda, Elvira [1 ,2 ,3 ]
Gomez-Bautista, Virginia [1 ,2 ,3 ]
Lopez, Iciar P. [1 ,2 ,3 ]
Lluis, Carmen [3 ]
Labandeira-Garcia, Jose L. [3 ,4 ]
Franco, Rafael [1 ,2 ,3 ]
机构
[1] Univ Navarra, Coll Med, Div Neurosci, Ctr Appl Med Res,CIMA, E-31080 Pamplona, Spain
[2] Univ Navarra, Coll Med, Ctr Appl Med Res, CIBERNAD, E-31080 Pamplona, Spain
[3] Univ Barcelona, CIBERNED, Dept Biochem & Mol Biol, E-08007 Barcelona, Spain
[4] Univ Santiago de Compostela, CIBERNED, Dept Morphol Sci, Santiago De Compostela, Spain
关键词
Basal ganglia; brain; endocannabinoids; in situ hybridization; levodopa; CB2; RECEPTORS; BASAL GANGLIA; PARKINSONS-DISEASE; MICROGLIAL CELLS; HUMAN BRAIN; RAT-BRAIN; LOCALIZATION; INVOLVEMENT; AFFERENTS; LIGANDS;
D O I
10.1177/0269881110367732
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The putative presence of the cannabinoid receptor type 2 (CB(2)-R) in the central nervous system is still a matter of debate. Although first described in peripheral and immune tissues, evidence suggesting the existence of CB(2)-Rs in glial cells and even neurons has been made available more recently. By taking advantage of newly designed CB(2)-R mRNA riboprobes, we have demonstrated by in situ hybridization and PCR the existence of CB(2)-R transcripts in a variety of brain areas of the primate Macaca fascicularis, including the cerebral cortex and the hippocampus, as well as in the external and internal divisions of the globus pallidus, both pallidal segments showing the highest abundance of CB(2)-R transcripts. In this regard, the presence of the messenger coding CB(2)-Rs within the pallidal complex highlights their consideration as potential targets for the treatment of movement disorders of basal ganglia origin.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 42 条
[1]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[2]  
[Anonymous], [No title captured]
[3]   Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study [J].
Ashton, JC ;
Friberg, D ;
Darlington, CL ;
Smith, PF .
NEUROSCIENCE LETTERS, 2006, 396 (02) :113-116
[4]   The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration [J].
Ashton, John C. ;
Glass, Michelle .
CURRENT NEUROPHARMACOLOGY, 2007, 5 (02) :73-80
[5]   Glutamatergic pallidothalamic projections and their implications in the pathophysiology of Parkinson's disease [J].
Barroso-Chinea, Pedro ;
Rico, Alberto J. ;
Perez-Manso, Monica ;
Roda, Elvira ;
Lopez, Iciar P. ;
Luis-Ravelo, Diego ;
Lanciego, Jose L. .
NEUROBIOLOGY OF DISEASE, 2008, 31 (03) :422-432
[6]   CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms [J].
Beltramo, M ;
Bernardini, N ;
Bertorelli, R ;
Campanella, M ;
Nicolussi, E ;
Fredduzzi, S ;
Reggiani, A .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 23 (06) :1530-1538
[7]  
Benito C, 2003, J NEUROSCI, V23, P11136
[8]   Ultrastructural Localization of Neuronal Brain CB2 Cannabinoid Receptors [J].
Brusco, A. ;
Tagliaferro, P. A. ;
Saez, T. ;
Onaivi, E. S. .
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES, 2008, 1139 :450-457
[9]   Postsynaptic Localization of CB2 Cannabinoid Receptors in the Rat Hippocampus [J].
Brusco, Alicia ;
Tagliaferro, Patricia ;
Saez, Trinidad ;
Onaivi, Emmanuel S. .
SYNAPSE, 2008, 62 (12) :944-949